Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia

ClinicalTrials.gov ID: NCT00549718

Public ClinicalTrials.gov record NCT00549718. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Placebo-Controlled, CLinical Trial to Study the Safety and Efficacy of Three Doses of Lurasidone HCl in Acutely Psychotic Patients With Schizophrenia

Study identification

NCT ID
NCT00549718
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
489 participants

Conditions and interventions

Conditions

Interventions

  • Lurasidone HCl Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2007
Primary completion
Sep 30, 2010
Completion
Sep 30, 2010
Last update posted
Jun 10, 2014

2007 – 2010

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
K&S Professional Research Services, LLC. Little Rock Arkansas 72201
Comprehensive Neuroscience, Inc Cerritos California 90703
Clinical Innovations, Inc. Costa Mesa California 92647
Collaborative Neuroscience Network Inc.,12772 Valley View Street,Suite 3 Garden Grove California 92645
California Clinical Trials Paramount California 90723
Pasadena Research Institute Pasadena California 91107
California Neuropsychopharmacology,CNRI - Los Angeles LLC,8309 Telegraph Road Pico Rivera California 90660
Sharp Mesa Vista Hospital San Diego California 92123
Comprehensive Neuroscience, Inc. Washington D.C. District of Columbia 20016
Florida Clinical Research Center, LLC Bradenton Florida 34208
Segal Institute for Clinical Research, Fidelity Clinical Research, Inc. North Miami Florida 33161
Atlanta Center for Medical Research Atlanta Georgia 30308
Alexian Brothers Health System Hoffman Estates Illinois 60169
Lake Charles Clinical Trials LLC Lake Charles Louisiana 70601
Booker, J. Gary, MD. APMC Shreveport Louisiana 71104
Center for Behavioral Health, LLC Rockville Maryland 20850
SUNY Downstate Medical Center Brooklyn New York 11203
Erie County Medical Center, Corp Buffalo New York 14215
CRI Worldwide LLC at Kirkbride Philadelphia Pennsylvania 19139
Research Strategies of Memphis, LLC. Memphis Tennessee 38119
Future Search Trials of Neurology Austin Texas 78756

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00549718, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2014 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00549718 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →